DK0927037T3 - Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider - Google Patents

Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider

Info

Publication number: DK0927037T3
Authority: DK; Denmark
Prior art keywords: chlorofluorocarbons; mometasone furoate; aerosol formulations; aerosol; formulations
Prior art date: 1996-08-29

Application number

DK97940582T

Other languages

Danish (da)

English (en)

Inventor

Julianne Berry

Joel A Sequeira

Imtiaz A Chaudry

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-29

Filing date

1997-08-26

Publication date

2001-09-24

1997-08-26 Application filed by Schering Corp filed Critical Schering Corp

2001-09-24 Application granted granted Critical

2001-09-24 Publication of DK0927037T3 publication Critical patent/DK0927037T3/da

Links

239000000443 aerosol Substances 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960002744 mometasone furoate Drugs 0.000 title 1
WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)

DK97940582T 1996-08-29 1997-08-26 Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider DK0927037T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70536896A	1996-08-29	1996-08-29
PCT/US1997/014708 WO1998008519A1 (en)	1996-08-29	1997-08-26	Chlorofluorocarbon-free mometasone furoate aerosol formulations

Publications (1)

Publication Number	Publication Date
DK0927037T3 true DK0927037T3 (da)	2001-09-24

Family

ID=24833161

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97940582T DK0927037T3 (da)	1996-08-29	1997-08-26	Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider

Country Status (30)

Country	Link
EP (1)	EP0927037B1 (de)
JP (1)	JP3264496B2 (de)
KR (1)	KR100316358B1 (de)
CN (1)	CN1162157C (de)
AR (1)	AR008309A1 (de)
AT (1)	ATE202936T1 (de)
AU (1)	AU719079B2 (de)
BR (1)	BR9711445A (de)
CA (1)	CA2263905C (de)
CO (1)	CO4900027A1 (de)
CZ (1)	CZ294064B6 (de)
DE (1)	DE69705628T2 (de)
DK (1)	DK0927037T3 (de)
ES (1)	ES2159148T3 (de)
GR (1)	GR3036674T3 (de)
HU (1)	HU227915B1 (de)
ID (1)	ID18137A (de)
IL (1)	IL128714A (de)
MY (1)	MY117377A (de)
NO (1)	NO322528B1 (de)
NZ (1)	NZ334112A (de)
PE (1)	PE100198A1 (de)
PL (1)	PL189036B1 (de)
PT (1)	PT927037E (de)
SA (1)	SA97180339B1 (de)
SK (1)	SK282147B6 (de)
TR (1)	TR199900379T2 (de)
TW (1)	TW475901B (de)
WO (1)	WO1998008519A1 (de)
ZA (1)	ZA977668B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5874481A (en) *	1995-06-07	1999-02-23	Alliance Pharmaceutical Corp.	Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US6946117B1 (en)	1997-09-29	2005-09-20	Nektar Therapeutics	Stabilized preparations for use in nebulizers
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6433040B1 (en)	1997-09-29	2002-08-13	Inhale Therapeutic Systems, Inc.	Stabilized bioactive preparations and methods of use
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US7442388B2 (en)	2000-05-10	2008-10-28	Weers Jeffry G	Phospholipid-based powders for drug delivery
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI324934B (en) *	2001-08-28	2010-05-21	Schering Corp	Pharmaceutical compositions for the treatment of asthma
US7368102B2 (en)	2001-12-19	2008-05-06	Nektar Therapeutics	Pulmonary delivery of aminoglycosides
GB0207906D0 (en)	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and mometasone aerosol formulations
CA2495689A1 (en) *	2002-08-23	2004-03-04	Schering Corporation	Pharmaceutical compositions
WO2004020289A1 (en) *	2002-08-27	2004-03-11	Schering Corporation	Process for producing metered dose inhaler formulations
EP1925293A3 (de) *	2003-10-20	2010-01-13	Schering Corporation	Pharmazeutische Aerosol-Zusammensetzungen
CA2542530A1 (en) *	2003-10-20	2005-05-12	Schering Corporation	Pharmaceutical aerosol compositions
EP2117504A1 (de) *	2007-02-09	2009-11-18	Schering Corporation	Stabile pharmazeutische wirkstoff-aerosole
CN107951893B (zh) *	2016-10-18	2022-04-26	天津金耀集团有限公司	一种糠酸莫米松粉吸入剂组合物
CN107961217B (zh) *	2016-10-18	2021-06-29	天津金耀集团有限公司	一种糠酸莫米松气雾剂组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5439670A (en) *	1989-11-28	1995-08-08	Riker Laboratories, Inc.	Medicinal aerosol formulations
DK1277467T3 (da) *	1991-06-10	2007-01-15	Schering Corp	Formuleringer af ikke-chlorfluorcarbonaerosoler
ES2200771T3 (es) *	1991-06-10	2004-03-16	Schering Corporation	Formulaciones en aerosol no clorofluorocarbonadas.
PE44995A1 (es) *	1994-01-27	1995-12-18	Schering Corp	Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

1997
- 1997-08-26 EP EP97940582A patent/EP0927037B1/de not_active Expired - Lifetime
- 1997-08-26 TW TW086112270A patent/TW475901B/zh not_active IP Right Cessation
- 1997-08-26 NZ NZ334112A patent/NZ334112A/xx not_active IP Right Cessation
- 1997-08-26 CO CO97049283A patent/CO4900027A1/es unknown
- 1997-08-26 PE PE1997000760A patent/PE100198A1/es not_active IP Right Cessation
- 1997-08-26 ZA ZA9707668A patent/ZA977668B/xx unknown
- 1997-08-26 WO PCT/US1997/014708 patent/WO1998008519A1/en not_active Ceased
- 1997-08-26 MY MYPI97003925A patent/MY117377A/en unknown
- 1997-08-26 SA SA97180339A patent/SA97180339B1/ar unknown
- 1997-08-26 JP JP51173198A patent/JP3264496B2/ja not_active Expired - Lifetime
- 1997-08-26 ID IDP972976A patent/ID18137A/id unknown
- 1997-08-26 PT PT97940582T patent/PT927037E/pt unknown
- 1997-08-26 IL IL12871497A patent/IL128714A/xx not_active IP Right Cessation
- 1997-08-26 DE DE69705628T patent/DE69705628T2/de not_active Expired - Lifetime
- 1997-08-26 HU HU9902675A patent/HU227915B1/hu unknown
- 1997-08-26 TR TR1999/00379T patent/TR199900379T2/xx unknown
- 1997-08-26 CZ CZ1999632A patent/CZ294064B6/cs not_active IP Right Cessation
- 1997-08-26 PL PL97331828A patent/PL189036B1/pl unknown
- 1997-08-26 DK DK97940582T patent/DK0927037T3/da active
- 1997-08-26 ES ES97940582T patent/ES2159148T3/es not_active Expired - Lifetime
- 1997-08-26 CA CA002263905A patent/CA2263905C/en not_active Expired - Lifetime
- 1997-08-26 AU AU42329/97A patent/AU719079B2/en not_active Expired
- 1997-08-26 KR KR1019997001588A patent/KR100316358B1/ko not_active Expired - Lifetime
- 1997-08-26 CN CNB97198980XA patent/CN1162157C/zh not_active Expired - Lifetime
- 1997-08-26 AR ARP970103860A patent/AR008309A1/es active IP Right Grant
- 1997-08-26 BR BR9711445A patent/BR9711445A/pt active Search and Examination
- 1997-08-26 SK SK253-99A patent/SK282147B6/sk not_active IP Right Cessation
- 1997-08-26 AT AT97940582T patent/ATE202936T1/de active
1999
- 1999-02-26 NO NO19990956A patent/NO322528B1/no not_active IP Right Cessation
2001
- 2001-09-20 GR GR20010401531T patent/GR3036674T3/el unknown

Also Published As

Publication number	Publication date
AU4232997A (en)	1998-03-19
ATE202936T1 (de)	2001-07-15
SA97180339B1 (ar)	2006-01-31
TR199900379T2 (xx)	1999-05-21
KR20000035879A (ko)	2000-06-26
HK1018206A1 (en)	1999-12-17
NO322528B1 (no)	2006-10-16
NO990956D0 (no)	1999-02-26
HUP9902675A2 (hu)	2000-01-28
WO1998008519A1 (en)	1998-03-05
CN1162157C (zh)	2004-08-18
GR3036674T3 (en)	2001-12-31
HU227915B1 (en)	2012-05-29
EP0927037B1 (de)	2001-07-11
CZ63299A3 (cs)	1999-07-14
SK282147B6 (sk)	2001-11-06
SK25399A3 (en)	1999-12-10
PL189036B1 (pl)	2005-06-30
CA2263905A1 (en)	1998-03-05
NO990956L (no)	1999-04-28
PL331828A1 (en)	1999-08-02
CZ294064B6 (cs)	2004-09-15
MY117377A (en)	2004-06-30
TW475901B (en)	2002-02-11
BR9711445A (pt)	1999-08-24
DE69705628D1 (de)	2001-08-16
IL128714A (en)	2003-05-29
CN1233960A (zh)	1999-11-03
HUP9902675A3 (en)	2000-02-28
EP0927037A1 (de)	1999-07-07
KR100316358B1 (ko)	2001-12-12
ZA977668B (en)	1998-02-26
ES2159148T3 (es)	2001-09-16
NZ334112A (en)	2000-07-28
JP2000503673A (ja)	2000-03-28
AR008309A1 (es)	1999-12-29
IL128714A0 (en)	2000-01-31
JP3264496B2 (ja)	2002-03-11
PT927037E (pt)	2001-10-31
AU719079B2 (en)	2000-05-04
ID18137A (id)	1998-03-05
DE69705628T2 (de)	2002-05-08
PE100198A1 (es)	1999-01-11
CO4900027A1 (es)	2000-03-27
CA2263905C (en)	2002-05-14

Publication	Publication Date	Title
NO985720D0 (no)	1998-12-07	Aerosol legemiddelformuleringer av formoterol
ATE236617T1 (de)	2003-04-15	Aerosol-arzneiformulierungen
IT1293803B1 (it)	1999-03-10	Formulazioni di aerosol medicinali
NO991407D0 (no)	1999-03-23	Legemiddelaerosolformuleringer som omfatter budesonid
DK1073417T3 (da)	2003-03-24	Farmaceutisk aerosolformulering
FI945524L (fi)	1995-05-28	Aerosolilääkekoostumuksia
DE69723854D1 (de)	2003-09-04	Stabile glasartige pulverformulierungen
FI921060A7 (fi)	1992-09-15	Farmaseuttiset aerosoliformulaatiot
DK0673240T3 (da)	1999-10-11	Stabiliserede medicinske aerosolopløsningsformuleringer
PT998272E (pt)	2003-09-30	Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
NO20004540D0 (no)	2000-09-12	Sammensetninger av peptider, formuleringer og anvendelse derav
IS2325B (is)	2007-12-15	Örgerðar samsetningar epleróns
BR9711445A (pt)	1999-08-24	Formula-{es em aerosol de furoato de mometasona isenta de clorofluorocarboneto
ID18832A (id)	1998-05-14	Komposisi insektisida
DK1014927T3 (da)	2003-10-13	Anvendelse af shogaoler og gingeroler til fremstilling af deodoriserende sammensætninger
ID23873A (id)	2000-05-25	Produk-produk semprot aerosol anti-perspiran mengandung alkohol
SE9404469D0 (sv)	1994-12-22	Aerosol formulations
DK1037604T3 (da)	2005-04-11	Farmaceutiske aerosolsammensætninger
HUP0001536A3 (en)	2001-02-28	Sulfonamide and carboxamide derivatives and pharmaceutical compositions containing the same as the active ingredient
ITMI920660A0 (it)	1992-03-23	Nuovo derivato di l-verbenone e composizioni farmaceutiche che lo contengono
ECSP951374A (es)	1996-01-15	Composiciones para pulverizaciones nasales